{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:32:17Z","timestamp":1792668737732,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"vor","delay-in-days":568,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100012728","name":"Frederick National Laboratory for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P30 GM124165"],"award-info":[{"award-number":["P30 GM124165"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN261200800001E"],"award-info":[{"award-number":["HHSN261200800001E"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10OD021527"],"award-info":[{"award-number":["S10OD021527"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006224","name":"Argonne National Laboratory","doi-asserted-by":"publisher","award":["S10_RR028976"],"award-info":[{"award-number":["S10_RR028976"]}],"id":[{"id":"10.13039\/100006224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006224","name":"Argonne National Laboratory","doi-asserted-by":"publisher","award":["S10_RR25528"],"award-info":[{"award-number":["S10_RR25528"]}],"id":[{"id":"10.13039\/100006224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006224","name":"Argonne National Laboratory","doi-asserted-by":"publisher","award":["DE-AC02-06CH11357"],"award-info":[{"award-number":["DE-AC02-06CH11357"]}],"id":[{"id":"10.13039\/100006224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006224","name":"Argonne National Laboratory","doi-asserted-by":"publisher","award":["S10_OD027000"],"award-info":[{"award-number":["S10_OD027000"]}],"id":[{"id":"10.13039\/100006224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013101","name":"National Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003896","name":"Henry M. Jackson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003896","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006751","name":"U.S. Army","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006132","name":"Office of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.immuni.2022.10.003","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T10:53:17Z","timestamp":1666867997000},"page":"2135-2148.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Epstein-Barr virus gH\/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition"],"prefix":"10.1016","volume":"55","author":[{"given":"Wei-Hung","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5443-8997","authenticated-orcid":false,"given":"JungHyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5208-9970","authenticated-orcid":false,"given":"Nathan L.","family":"Board","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaroslav","family":"Tsybovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Hostal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah F.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5741-3699","authenticated-orcid":false,"given":"Rebecca A.","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misook","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Sung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amarendra","family":"Pegu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline E.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian E.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5293-4695","authenticated-orcid":false,"given":"John R.","family":"Mascola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7688-1439","authenticated-orcid":false,"given":"Stefania","family":"Pittaluga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian B.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5767-1532","authenticated-orcid":false,"given":"Masaru","family":"Kanekiyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6808-7232","authenticated-orcid":false,"given":"M. Gordon","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey I.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2022.10.003_bib45","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.immuni.2022.10.003_bib1","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.immuni.2019.03.010","article-title":"Immunization with components of the viral fusion apparatus elicits antibodies that neutralize Epstein-Barr virus in B cells and epithelial cells","volume":"50","author":"Bu","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2022.10.003_bib2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41564-017-0081-7","article-title":"Ephrin receptor A2 is a functional entry receptor for Epstein-Barr virus","volume":"3","author":"Chen","year":"2018","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.immuni.2022.10.003_bib3","doi-asserted-by":"crossref","first-page":"20464","DOI":"10.1073\/pnas.0907508106","article-title":"Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins alphavbeta6 or alphavbeta8","volume":"106","author":"Chesnokova","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2022.10.003_bib4","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/nsmb.1837","article-title":"Crystal structure of the conserved herpesvirus fusion regulator complex gH-gL","volume":"17","author":"Chowdary","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.immuni.2022.10.003_bib44","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein-Barr virus infection","volume":"343","author":"Cohen","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.immuni.2022.10.003_bib5","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1016\/j.vaccine.2016.06.021","article-title":"Rabbits immunized with Epstein-Barr virus gH\/gL or gB recombinant proteins elicit higher serum virus neutralizing activity than gp350","volume":"34","author":"Cui","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.immuni.2022.10.003_bib6","doi-asserted-by":"crossref","first-page":"8245","DOI":"10.1073\/pnas.95.14.8245","article-title":"Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells","volume":"95","author":"Delecluse","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2022.10.003_bib7","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/jsbi.1996.0030","article-title":"Spider and WEB: processing and visualization of images in 3D electron microscopy and related fields","volume":"116","author":"Frank","year":"1996","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.immuni.2022.10.003_bib8","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1128\/JVI.00121-16","article-title":"Monoclonal antibodies to different components of the human cytomegalovirus (HCMV) pentamer gH\/gL\/pUL128L and trimer gH\/gL\/gO as well as antibodies elicited during primary HCMV infection prevent epithelial cell syncytium formation","volume":"90","author":"Gerna","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2022.10.003_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jsb.2006.05.004","article-title":"FREALIGN: high-resolution refinement of single particle structures","volume":"157","author":"Grigorieff","year":"2007","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.immuni.2022.10.003_bib10","doi-asserted-by":"crossref","first-page":"16082","DOI":"10.1038\/nmicrobiol.2016.82","article-title":"Platelet-derived growth factor-alpha receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer","volume":"1","author":"Kabanova","year":"2016","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.immuni.2022.10.003_bib11","doi-asserted-by":"crossref","first-page":"17965","DOI":"10.1073\/pnas.1415310111","article-title":"Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies","volume":"111","author":"Kabanova","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2022.10.003_bib12","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.cell.2015.07.043","article-title":"Rational design of an Epstein-Barr virus vaccine targeting the receptor-binding site","volume":"162","author":"Kanekiyo","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2022.10.003_bib13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virol.2021.06.006","article-title":"Epstein-Barr virus (EBV) hyperimmune globulin isolated from donors with high gp350 antibody titers protect humanized mice from challenge with EBV","volume":"561","author":"Kim","year":"2021","journal-title":"Virology"},{"key":"10.1016\/j.immuni.2022.10.003_bib14","doi-asserted-by":"crossref","first-page":"9216","DOI":"10.1128\/JVI.00575-07","article-title":"Binding-site interactions between Epstein-Barr virus fusion proteins gp42 and gH\/gL reveal a peptide that inhibits both epithelial and B-cell membrane fusion","volume":"81","author":"Kirschner","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2022.10.003_bib15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jmb.2010.08.033","article-title":"Expression-system-dependent modulation of HIV-1 envelope glycoprotein antigenicity and immunogenicity","volume":"403","author":"Kong","year":"2010","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.immuni.2022.10.003_bib16","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.cell.2021.01.036","article-title":"Structures of HCMV trimer reveal the basis for receptor recognition and cell entry","volume":"184","author":"Kschonsak","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2022.10.003_bib46","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2022.10.003_bib17","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/nm.4224","article-title":"Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination","volume":"22","author":"Lee","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2022.10.003_bib18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41541-021-00342-3","article-title":"A conditionally replication-defective cytomegalovirus vaccine elicits potent and diverse functional monoclonal antibodies in a phase I clinical trial","volume":"6","author":"Li","year":"2021","journal-title":"npj Vaccines"},{"key":"10.1016\/j.immuni.2022.10.003_bib49","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/356347a0","article-title":"Epstein-Barr virus infection and replication in a human epithelial cell system","volume":"356","author":"Li","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2022.10.003_bib19","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/JVI.01809-09","article-title":"Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH\/gL\/UL128-131A complex","volume":"84","author":"Macagno","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2022.10.003_bib20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","article-title":"Automated electron microscope tomography using robust prediction of specimen movements","volume":"152","author":"Mastronarde","year":"2005","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.immuni.2022.10.003_bib21","doi-asserted-by":"crossref","first-page":"22641","DOI":"10.1073\/pnas.1011806108","article-title":"Crystal structure of the Epstein-Barr virus (EBV) glycoprotein H\/glycoprotein L (gH\/gL) complex","volume":"107","author":"Matsuura","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2022.10.003_bib22","doi-asserted-by":"crossref","first-page":"17474","DOI":"10.1073\/pnas.0404535101","article-title":"Cell-surface expression of a mutated Epstein-Barr virus glycoprotein B allows fusion independent of other viral proteins","volume":"101","author":"McShane","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2022.10.003_bib23","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1128\/JVI.74.14.6324-6332.2000","article-title":"Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells","volume":"74","author":"Molesworth","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2022.10.003_bib48","doi-asserted-by":"crossref","first-page":"12408","DOI":"10.1128\/JVI.79.19.12408-12415.2005","article-title":"The amino terminus of Epstein-Barr virus glycoprotein gH is important for fusion with epithelial and B cells","volume":"79","author":"Omerovi\u0107","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.immuni.2022.10.003_bib24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.immuni.2022.10.003_bib25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2818.1987.tb01333.x","article-title":"Three-dimensional reconstruction from a single-exposure, random conical tilt series applied to the 50S ribosomal subunit of Escherichia coli","volume":"146","author":"Radermacher","year":"1987","journal-title":"J.\u00a0Microsc."},{"key":"10.1016\/j.immuni.2022.10.003_bib26","doi-asserted-by":"crossref","first-page":"13557","DOI":"10.1038\/ncomms13557","article-title":"Structural basis for Epstein-Barr virus host cell tropism mediated by gp42 and gHgL entry glycoproteins","volume":"7","author":"Sathiyamoorthy","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2022.10.003_bib27","doi-asserted-by":"crossref","first-page":"E8703","DOI":"10.1073\/pnas.1704661114","article-title":"Inhibition of EBV-mediated membrane fusion by anti-gHgL antibodies","volume":"114","author":"Sathiyamoorthy","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2022.10.003_bib28","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jsb.2012.09.006","article-title":"RELION: implementation of a Bayesian approach to cryo-EM structure determination","volume":"180","author":"Scheres","year":"2012","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.immuni.2022.10.003_bib29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1203\/00006450-199510000-00001","article-title":"X-linked lymphoproliferative disease: twenty-five years after the discovery","volume":"38","author":"Seemayer","year":"1995","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.immuni.2022.10.003_bib30","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/nprot.2008.156","article-title":"Spider image processing for single-particle reconstruction of biological macromolecules from electron micrographs","volume":"3","author":"Shaikh","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.immuni.2022.10.003_bib47","doi-asserted-by":"crossref","first-page":"5946","DOI":"10.1128\/JVI.78.11.5946-5956.2004","article-title":"Mutational analyses of Epstein-Barr virus glycoprotein 42 reveal functional domains not involved in receptor binding but required for membrane fusion","volume":"78","author":"Silva","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.immuni.2022.10.003_bib31","first-page":"100033","article-title":"Neutralizing antibodies protect against oral transmission of Lymphocryptovirus. Cell","volume":"1","author":"Singh","year":"2020","journal-title":"Reprod. Med."},{"key":"10.1016\/j.immuni.2022.10.003_bib32","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.immuni.2018.03.026","article-title":"An antibody targeting the fusion machinery neutralizes dual-tropic infection and defines a site of vulnerability on Epstein-Barr virus","volume":"48","author":"Snijder","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2022.10.003_bib33","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00007890-198411000-00026","article-title":"A pilot trial of a novel cytomegalovirus immune globulin in renal transplant recipients","volume":"38","author":"Snydman","year":"1984","journal-title":"Transplantation"},{"key":"10.1016\/j.immuni.2022.10.003_bib34","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.1128\/jvi.70.8.5557-5563.1996","article-title":"The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation","volume":"70","author":"Spriggs","year":"1996","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2022.10.003_bib35","doi-asserted-by":"crossref","first-page":"5964","DOI":"10.1038\/s41467-020-19617-9","article-title":"Molecular basis of EphA2 recognition by gHgL from gammaherpesviruses","volume":"11","author":"Su","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2022.10.003_bib36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsb.2006.05.009","article-title":"EMAN2: an extensible image processing suite for electron microscopy","volume":"157","author":"Tang","year":"2007","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.immuni.2022.10.003_bib37","doi-asserted-by":"crossref","first-page":"9075","DOI":"10.1016\/j.vaccine.2011.09.056","article-title":"Quantitative analysis of neutralizing antibody response to human cytomegalovirus in natural infection","volume":"29","author":"Wang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.immuni.2022.10.003_bib38","doi-asserted-by":"crossref","first-page":"eabf3685","DOI":"10.1126\/scitranslmed.abf3685","article-title":"A bivalent Epstein-Barr virus vaccine induces neutralizing antibodies that block infection and confer immunity in humanized mice","volume":"14","author":"Wei","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2022.10.003_bib39","doi-asserted-by":"crossref","first-page":"eabm2546","DOI":"10.1126\/sciadv.abm2546","article-title":"Structural basis for HCMV pentamer recognition by neuropilin 2 and neutralizing antibodies","volume":"8","author":"Wrapp","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.immuni.2022.10.003_bib40","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.virol.2007.01.025","article-title":"Point mutations in EBV gH that abrogate or differentially affect B cell and epithelial cell fusion","volume":"363","author":"Wu","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.immuni.2022.10.003_bib41","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1073\/pnas.1501176112","article-title":"A site of varicella-zoster virus vulnerability identified by structural studies of neutralizing antibodies bound to the glycoprotein complex gHgL","volume":"112","author":"Xing","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2022.10.003_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41564-017-0080-8","article-title":"Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry","volume":"3","author":"Zhang","year":"2018","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.immuni.2022.10.003_bib43","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.1038\/s41467-021-26912-6","article-title":"A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus","volume":"12","author":"Zhu","year":"2021","journal-title":"Nat. Commun."}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761322005441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761322005441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:11:00Z","timestamp":1778587860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761322005441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1074761322005441"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2022.10.003","relation":{},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epstein-Barr virus gH\/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2022.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}